These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23013459)

  • 1. When to start, what to start and other treatment controversies in pediatric HIV infection.
    Turkova A; Webb RH; Lyall H
    Paediatr Drugs; 2012 Dec; 14(6):361-76. PubMed ID: 23013459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
    Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PENTA guidelines for the use of antiretroviral therapy, 2004.
    Sharland M; Blanche S; Castelli G; Ramos J; Gibb DM;
    HIV Med; 2004 Jul; 5 Suppl 2():61-86. PubMed ID: 15239717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of antiretroviral therapy in HIV-infected children under 3 years of age: a systematic review.
    Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams EJ
    AIDS; 2014 Mar; 28 Suppl 2():S137-46. PubMed ID: 24849473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    ; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
    PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of individuals requiring antiretroviral therapy and TB treatment.
    Cohen K; Meintjes G
    Curr Opin HIV AIDS; 2010 Jan; 5(1):61-9. PubMed ID: 20046149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.
    Bamford A; Turkova A; Lyall H; Foster C; Klein N; Bastiaans D; Burger D; Bernadi S; Butler K; Chiappini E; Clayden P; Della Negra M; Giacomet V; Giaquinto C; Gibb D; Galli L; Hainaut M; Koros M; Marques L; Nastouli E; Niehues T; Noguera-Julian A; Rojo P; Rudin C; Scherpbier HJ; Tudor-Williams G; Welch SB;
    HIV Med; 2018 Jan; 19(1):e1-e42. PubMed ID: 25649230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future antiretroviral treatment options in paediatric HIV infection.
    Giaquinto C; Morelli E; Fregonese F; Rampon O; Penazzato M; de Rossi A; D'Elia R
    Clin Drug Investig; 2008; 28(6):375-97. PubMed ID: 18479179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection.
    ; Welch S; Sharland M; Lyall EG; Tudor-Williams G; Niehues T; Wintergerst U; Bunupuradah T; Hainaut M; Della Negra M; Pena MJ; Amador JT; Gattinara GC; Compagnucci A; Faye A; Giaquinto C; Gibb DM; Gandhi K; Forcat S; Buckberry K; Harper L; Königs C; Patel D; Bastiaans D
    HIV Med; 2009 Nov; 10(10):591-613. PubMed ID: 19878352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.
    Babiker AG; Emery S; Fätkenheuer G; Gordin FM; Grund B; Lundgren JD; Neaton JD; Pett SL; Phillips A; Touloumi G; Vjechaj MJ;
    Clin Trials; 2013; 10(1 Suppl):S5-S36. PubMed ID: 22547421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
    Bonnet M; Bhatt N; Baudin E; Silva C; Michon C; Taburet AM; Ciaffi L; Sobry A; Bastos R; Nunes E; Rouzioux C; Jani I; Calmy A;
    Lancet Infect Dis; 2013 Apr; 13(4):303-12. PubMed ID: 23433590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.